⌘K
t
Craneware plc shareholders, at a General Meeting held on 20 August 2025, approved all four resolutions related to a proposed capital reduction. These resolutions, which included the capitalisation of the merger reserve, the allotment and subsequent cancellation of B ordinary shares, and the cancellation of the share premium account, each passed with 100.00% of votes cast in favour. A total of 69.22% of the Company's 35,409,802 voting rights were instructed, and the capital reduction remains conditional upon confirmation from the Court of Session.
| Date | 20 Aug 2025 |
| Time | 18:22:55 |
| Category | AGMs and other meetings |
| ID | 1617W |
The headline for the Craneware plc announcement released on 20 August 2025 at 16:28 under RNS No 1424W should read Result of General Meeting.
The announcement text is unchanged and is reproduced in full below.
Craneware plc
("Craneware" or the "Company")
Result of General Meeting
20 August 2025 - Craneware (AIM: CRW.L), a leader in healthcare financial performance solutions, announces that at a general meeting of the Company (the "General Meeting") held earlier today, at Tanfield House, 1 Tanfield, Edinburgh, EH3 5DA, UK, the resolutions to approve the proposed capital reduction were voted on by shareholders, by way of a poll, and were duly approved.
Details of the resolutions were set out in the circular posted to shareholders on 1 August 2025 which can also be found on the Company's website at www.thecranewaregroup.com.
|
No. |
Resolution |
Votes For (a) |
% For |
Votes Against |
% Against |
Votes Withheld (b) |
Total |
|
1 |
To capitalise the merger reserve of the Company and authorise the directors to allot unissued B ordinary shares |
24,506,336 |
100.00 |
343 |
0.00 |
4,665 |
24,511,344 |
|
2 |
To set out the rights and restrictions attaching to the B ordinary shares |
24,510,788 |
100.00 |
343 |
0.00 |
213 |
24,511,344 |
|
3 |
To reduce the capital of the Company by cancelling and extinguishing the B Ordinary Shares allotted and issued pursuant to resolution 1 and to credit the amount of such reduction to the reserves of the Company |
24,511,131 |
100.00 |
0 |
0.00 |
213 |
24,511,344 |
|
4 |
To cancel the share premium account of the Company and to credit the amount of such reduction to the reserves of the Company |
24,511,131 |
100.00 |
0 |
0.00 |
213 |
24,511,344 |
Notes:
(a) The 'For' votes include those proxy votes which gave the Chair discretion.
(b) A vote withheld is not a vote in law and is not counted in the calculation of the votes 'For' or 'Against' the resolution.
(c) All resolutions put to the General Meeting were special resolutions.
The total number of Ordinary Shares of the Company in issue (excluding shares held in Treasury) on 18 August 2025, the deadline for casting votes by proxy in advance of the General Meeting, was 35,409,802 Ordinary Shares. 69.22 per cent of the total voting rights in the Company was instructed in respect of the resolutions put to the General Meeting.
The Company's shareholders should note that the proposed reduction of capital is conditional upon confirmation being obtained from the Court of Session, Edinburgh, Scotland (the "Court").
EXPECTED TIMETABLE OF PRINCIPAL EVENTS
|
Expected date of the first Court hearing for initial directions |
in or around late August 2025 |
|
Capital Reduction Record Time |
6.30 p.m. on the Business Day preceding the Court hearing to confirm the Reduction of Capital |
|
Expected date of the second Court hearing to confirm the Reduction of Capital |
in or around October 2025 |
|
Effective Date of the Reduction of Capital |
Business Day after the Court order confirming the Reduction of Capital |
Notes: Each of the times and dates, as set out in the Expected Timetable of Principal Events above, is based on current expectations and is subject to change. If any of the above times and/or dates is changed, the revised times and/or dates will be notified to Shareholders by announcement through a regulatory information service. All above references to times are to London times.
For further information, please contact:
|
Craneware plc |
+44 (0)131 550 3100 |
|
Keith Neilson, CEO |
|
|
Craig Preston, CFO |
|
|
|
|
|
Alma Strategic Communications (Financial PR) |
+44 (0)20 3405 0205 |
|
Caroline Forde, Kinvara Verdon, Sarah Peters |
craneware@almastrategic.com |
|
|
|
|
Peel Hunt (NOMAD and Joint Broker) |
+44 (0)20 7418 8900 |
|
Neil Patel, Benjamin Cryer, Kate Bannatyne |
|
|
|
|
|
Investec Bank PLC (Joint Broker) |
+44 (0)20 7597 5970 |
|
Patrick Robb, Virginia Bull, James Smith |
|
|
|
|
|
Berenberg (Joint Broker) |
+44 (0)20 3207 7800 |
|
Mark Whitmore, Richard Andrews, Patrick Dolaghan |
|
About The Craneware Group
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth.
As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster-that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider.
The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve-today and in the future. Together, we are transforming the business of healthcare.
Learn more at www.thecranewaregroup.com